Patrys secures ethics approval for Phase 1A clinical trial on delirium candidate
Patrys has received HREC approval to commence its Phase 1A clinical trial of RLS-2202 for the treatment of delirium in acute care settings.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Kaizen Global Investments Limited
| Forum | Tag | Subject | View | Poster | |||||
|---|---|---|---|---|---|---|---|---|---|
| NSX - By Stock | KGI | Ann:NTA Valuation for March 2018 (Price Sensitive) | Thread |
NSX News
|
0 | 43 | 0 | 16/04/18 | |
|
|||||||||
| NSX - By Stock | KGI | Ann:NTA valuation for February 2018 (Price Sensitive) | Thread |
NSX News
|
0 | 85 | 0 | 13/03/18 | |
|
|||||||||
| NSX - By Stock | KGI | Ann:Financial Report for Half-year to 31 December 2017 (Price Sensitive) | Thread |
NSX News
|
0 | 69 | 0 | 28/02/18 | |
|
|||||||||
NSX News